1. Home
  2. COLL vs LQDT Comparison

COLL vs LQDT Comparison

Compare COLL & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • LQDT
  • Stock Information
  • Founded
  • COLL 2002
  • LQDT 1999
  • Country
  • COLL United States
  • LQDT United States
  • Employees
  • COLL N/A
  • LQDT N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • LQDT Catalog/Specialty Distribution
  • Sector
  • COLL Health Care
  • LQDT Consumer Discretionary
  • Exchange
  • COLL Nasdaq
  • LQDT Nasdaq
  • Market Cap
  • COLL 958.8M
  • LQDT 773.6M
  • IPO Year
  • COLL 2015
  • LQDT 2006
  • Fundamental
  • Price
  • COLL $30.13
  • LQDT $23.57
  • Analyst Decision
  • COLL Strong Buy
  • LQDT Strong Buy
  • Analyst Count
  • COLL 4
  • LQDT 2
  • Target Price
  • COLL $43.75
  • LQDT $38.50
  • AVG Volume (30 Days)
  • COLL 287.8K
  • LQDT 271.5K
  • Earning Date
  • COLL 08-07-2025
  • LQDT 08-07-2025
  • Dividend Yield
  • COLL N/A
  • LQDT N/A
  • EPS Growth
  • COLL N/A
  • LQDT 23.09
  • EPS
  • COLL 1.25
  • LQDT 0.79
  • Revenue
  • COLL $664,283,000.00
  • LQDT $439,246,000.00
  • Revenue This Year
  • COLL $20.04
  • LQDT $35.02
  • Revenue Next Year
  • COLL $3.98
  • LQDT $9.90
  • P/E Ratio
  • COLL $23.59
  • LQDT $29.72
  • Revenue Growth
  • COLL 17.17
  • LQDT 35.78
  • 52 Week Low
  • COLL $23.23
  • LQDT $19.31
  • 52 Week High
  • COLL $42.29
  • LQDT $39.72
  • Technical
  • Relative Strength Index (RSI)
  • COLL 55.25
  • LQDT 46.09
  • Support Level
  • COLL $29.11
  • LQDT $22.89
  • Resistance Level
  • COLL $30.30
  • LQDT $23.87
  • Average True Range (ATR)
  • COLL 0.71
  • LQDT 0.67
  • MACD
  • COLL -0.03
  • LQDT 0.19
  • Stochastic Oscillator
  • COLL 44.32
  • LQDT 52.78

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

Share on Social Networks: